Chronic cough

💊 Behandelingen bij chronic cough

Gerangschikt op onderbouwing (aantal onafhankelijke bronnen) en gerapporteerde frequentie.

+ Enkel op voorschrift — bespreek met je arts

• +LYFNUA 45 mg cp pellic1 bronniet vrij verkrijgbaar — vraag je arts
• +Ranibizumab1 bronniet vrij verkrijgbaar — vraag je arts
  About the substance

  A humanized recombinant monoclonal antibody fragment that acts as a VEGF-A inhibitor. It binds to VEGF-A and prevents interaction with VEGFR-1 and VEGFR-2 receptors, thereby inhibiting endothelial cell proliferation, neovascularization, and vascular leakage.

  Dosage: 0.5 mg (0.05 ml) via intravitreal injection, with an interval of at least four weeks between doses in the same eye.
• +Imatinib1 bronop voorschrift — vraag je arts
  About the substance

  Imatinib is a BCR-ABL tyrosine kinase inhibitor that specifically blocks the activity of Bcr-Abl, Kit, DDR, and PDGFR receptor kinases. By inhibiting these signaling pathways, it stops the uncontrolled proliferation of malignant cells.

  Dosage: 400 mg or 600 mg once daily, or 800 mg (as 400 mg twice daily). Take orally during a meal with a large glass of water.
• +Bevacizumab1 bronniet vrij verkrijgbaar — vraag je arts
  About the substance

  A humanized monoclonal IgG antibody that binds to and neutralizes VEGF (vascular endothelial growth factor), thereby inhibiting angiogenesis and tumor vascularization.

  Dosage: Intravenous infusion: 5-10 mg/kg every 2 weeks or 7.5-15 mg/kg every 3 weeks, depending on the indication.

Bron: dis-treat master (BCFI/itreat · EMA · SIDER · FAERS-frequentie). Geen diagnose — dit vervangt geen consult.